What would you use as adjuvant endocrine therapy for a patient who developed an invasive, hormone receptor positive breast cancer while on raloxifene for almost a decade prior?  

Out of curiosity, I did tumor testing, and she does not have an activating ESR1 mutation.

Answer from: Medical Oncologist at Academic Institution